Dr howard fillet biography of abraham

Announcements

NEW YORK – February 12, 2024 – The Alzheimer’s Drug Discovery Foundation (ADDF) is pleased to announce its founders will play a significant role in this year’s AD/PD™ 2024 International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders, from March 5^th to 9^th, in Lisbon, Portugal.

The ADDF’s Co-Chairman and Co-Founder, Ronald S. Lauder, will participate in the inaugural Fireside Chat and ADDF Co-Founder and Chief Science Officer, Howard Fillit, MD, will deliver a keynote titled, “Translating the Biology of Aging Into New Therapeutics for Alzheimer’s Disease,” focusing on the next frontier of Alzheimer’s treatment—combination therapy and precision medicine.

“We are witnessing remarkable momentum in Alzheimer’s